Healthcare Business

Why Investors Shouldn’t Sleep on This Narcolepsy Study

Axsome Therapeutics Inc. (NASDAQ: AXSM) shares jumped early on Tuesday after the firm announced positive results from its midstage narcolepsy trial. Specifically, the results come from the Phase 2 Concert ...
Read Full Story »

Why This Atopic Dermatitis Study Was So Well Received

Aslan Pharmaceuticals Ltd. (NASDAQ: ASLN) shares jumped on Monday after the firm announced positive preliminary data from the lowest dose cohort of its ongoing multiple ascending dose study of ASLAN004 ...
Read Full Story »

Why This Seizure Treatment Could Be the Next Big Thing

Aquestive Therapeutics Inc. (NASDAQ: AQST) shares jumped early on Monday after the firm announced the completion of its rolling submission of a New Drug Application (NDA) to the U.S. Food ...
Read Full Story »

Major Biopharma Catalysts on the December FDA Calendar

Companies in the biotech and pharmaceutical industries are subject to a sizable amount of risk with regards to their drug candidates passing clinical trials and gaining regulatory approval. But with ...
Read Full Story »

Big Pharma Short Sellers Hike Their Bets

Pharmaceutical companies usually are involved in a lengthy process of getting their drug candidates to market through clinical trials. There is a fair amount of risk involved, should a study ...
Read Full Story »

Short Sellers Run For Cover From Major Biotechs

The short interest data are out for the most recent settlement date, November 15. Generally speaking, companies within the biotech industry are considered a riskier group of stocks, with big ...
Read Full Story »

Starboard Value Stake Momentarily Shakes Up CVS

A report Monday in the Wall Street Journal put a bit of air under shares of CVS Health Corp. (NYSE: CVS). The drugstore, pharmacy benefits manager, and health insurer has ...
Read Full Story »

What This Study For ANCA Vasculitis Means Going Forward

ChemoCentryx, Inc. (NASDAQ: CCXI) shares more than tripled on Tuesday after the firm, in conjunction with Vifor Fresenius Medical Care Renal Pharma, announced positive topline data from its late-stage trial ...
Read Full Story »

Why This Newly FDA Approved Sickle Cell Treatment Will Be Huge

Global Blood Therapeutics, Inc. (NASDAQ: GBT) shares jumped on Tuesday after the firm announced that the U.S. Food and Drug Administration (FDA) has granted accelerated approval for Oxbryta (voxelotor) tablets ...
Read Full Story »

Novartis Finally Comes Through With Its Acquisition of Medicines Co

Medicines Co. (NASDAQ: MDCO) shares shot up on Monday after it was reported that Novartis A.G. (NYSE: NVS) will be acquiring the firm. The transaction was unanimously approved by the ...
Read Full Story »

A Big Step Forward For the Treatment of ALS

Aquestive Therapeutics, Inc. (NASDAQ: AQST) shares jumped on Monday after the firm announced that its treatment of amyotrophic lateral sclerosis (ALS), Exservan, received early-action approval from the U.S. Food and ...
Read Full Story »

Metastatic Melanoma Study Mixed Results Could Be a Positive

Iovance Biotherapeutics Inc. (NASDAQ: IOVA) announced results from a subgroup analysis of metastatic melanoma patients in its Phase 2 study of lifileucel. These results were released in an abstract for ...
Read Full Story »

ProQR Therapeutics Takes a Big Step Forward With Its Latest FDA Approval

ProQR Therapeutics N.V. (NASDAQ: PRQR) shares jumped early on Thursday after the firm announced that it received Orphan Drug designation (ODD) from the U.S. Food and Drug Administration (FDA) for ...
Read Full Story »

A Big Step Forward in the Fight Against Ovarian Cancer

Aravive Inc. (NASDAQ: ARAV) shares skyrocketed on Wednesday after the firm announced early-stage data for its ovarian cancer treatment. Specifically, the results are from the ongoing Phase 1b portion of ...
Read Full Story »

Why This FDA Breakthrough Is a Big Deal for Recurrent Pericarditis Patients

Kiniksa Pharmaceuticals Ltd. (NASDAQ: KNSA) shares jumped on Wednesday after the firm announced that the U.S. Food and Drug Administration (FDA) granted Breakthrough Therapy designation for rilonacept for the treatment ...
Read Full Story »